BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18157008)

  • 1. Enhanced immunity to intracerebral breast cancer in mice immunized with a cDNA-based vaccine enriched for immunotherapeutic cells.
    Lichtor T; Glick RP; Feldman LA; Osawa G; Hardman J; O- Sullivan I; Cohen EP
    J Immunother; 2008 Jan; 31(1):18-27. PubMed ID: 18157008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumoral injection of IL-secreting syngeneic/allogeneic fibroblasts transfected with DNA from breast cancer cells prolongs the survival of mice with intracerebral breast cancer.
    Lichtor T; Glick RP; Lin H; O-Sullivan I; Cohen EP
    Cancer Gene Ther; 2005 Aug; 12(8):708-14. PubMed ID: 15803143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced immunity to breast cancer in mice immunized with fibroblasts transfected with a complementary DNA expression library from breast cancer cells: Enrichment of the vaccine for immunotherapeutic cells.
    Kim TS; Chopra A; O-Sullivan IS; Cohen EP
    J Immunother; 2006; 29(3):261-73. PubMed ID: 16699369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of the survival of breast cancer-bearing mice immunized with GM-CSF-secreting syngeneic/allogeneic fibroblasts transfected with a cDNA expression library from breast cancer cells.
    Kim TS; Jung MY; Cho D; Cohen EP
    Vaccine; 2006 Oct; 24(42-43):6564-73. PubMed ID: 16837111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunity to growth factor receptor-bound protein 10, a signal transduction molecule, inhibits the growth of breast cancer in mice.
    O-Sullivan I; Chopra A; Carr J; Kim TS; Cohen EP
    Cancer Res; 2008 Apr; 68(7):2463-70. PubMed ID: 18381455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to breast cancer in mice immunized with fibroblasts transfected with a cDNA expression library derived from small numbers of breast cancer cells.
    Sung Kim T; Cohen EP
    Cancer Gene Ther; 2005 Nov; 12(11):890-9. PubMed ID: 15905859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-regulatory cells are relatively deficient in squamous carcinomas undergoing regression in mice immunized with a squamous carcinoma vaccine enriched for immunotherapeutic cells.
    Chopra A; O-Sullivan I; Carr J; Kim TS; Cohen EP
    Cancer Gene Ther; 2007 Jun; 14(6):573-82. PubMed ID: 17384578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma.
    O-Sullivan I; Kim TS; Chopra A; Cohen EP
    Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogene therapy.
    Lichtor T; Glick RP
    Adv Exp Med Biol; 2012; 746():151-65. PubMed ID: 22639166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of breast cancer with fibroblasts transfected with DNA from breast cancer cells.
    de Zoeten E; Carr-Brendel V; Markovic D; Taylor-Papadimitriou J; Cohen EP
    J Immunol; 1999 Jun; 162(11):6934-41. PubMed ID: 10352316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New strategy for the identification of squamous carcinoma antigens that induce therapeutic immune responses in tumor-bearing mice.
    O-Sullivan I; Chopra A; Kim TS; Magnuson S; Falduto MT; Huang J; Cohen EP
    Cancer Gene Ther; 2007 Apr; 14(4):389-98. PubMed ID: 17273183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single administration of low dose cyclophosphamide augments the antitumor effect of dendritic cell vaccine.
    Liu JY; Wu Y; Zhang XS; Yang JL; Li HL; Mao YQ; Wang Y; Cheng X; Li YQ; Xia JC; Masucci M; Zeng YX
    Cancer Immunol Immunother; 2007 Oct; 56(10):1597-604. PubMed ID: 17440723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR; Holst PJ; Pircher H; Christensen JP; Thomsen AR
    Eur J Immunol; 2009 Oct; 39(10):2725-36. PubMed ID: 19637230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of interleukin-2-secreting syngeneic/allogeneic fibroblasts in the treatment of primary and metastatic brain tumors.
    Lichtor T; Glick RP; Tarlock K; Moffett S; Mouw E; Cohen EP
    Cancer Gene Ther; 2002 May; 9(5):464-9. PubMed ID: 11961669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and cellular immunity induced by tumor cell vaccine based on the chicken xenogeneic homologous matrix metalloproteinase-2.
    Yi T; Wei YQ; Tian L; Zhao X; Li J; Deng HX; Wen YJ; Zou CH; Tan GH; Kan B; Su JM; Jiang Y; Mao YQ; Chen P; Wang YS
    Cancer Gene Ther; 2007 Feb; 14(2):158-64. PubMed ID: 17124509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
    Sypniewska RK; Hoflack L; Tarango M; Gauntt S; Leal BZ; Reddick RL; Gravekamp C
    Breast Cancer Res Treat; 2005 May; 91(1):19-28. PubMed ID: 15868428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to melanoma in mice immunized with semiallogeneic fibroblasts transfected with DNA from mouse melanoma cells.
    de Zoeten EF; Carr-Brendel V; Cohen EP
    J Immunol; 1998 Mar; 160(6):2915-22. PubMed ID: 9510195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent anti-tumor-preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.
    Mortara L; Frangione V; Castellani P; De Lerma Barbaro A; Accolla RS
    Int Immunol; 2009 Jun; 21(6):655-65. PubMed ID: 19395374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer.
    Williams BB; Wall M; Miao RY; Williams B; Bertoncello I; Kershaw MH; Mantamadiotis T; Haber M; Norris MD; Gautam A; Darcy PK; Ramsay RG
    Cancer Immunol Immunother; 2008 Nov; 57(11):1635-45. PubMed ID: 18386000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.